
Help us make a
difference sooner...

The Draigon Consortium proposes to validate and demonstrate the clinical efficacy of
a novel diagnostic test focusing on blood and periprosthetic joint infections at five hospitals in the Netherlands, Austria, Albania and the United States.
The DRAIGON Consortium plans to demonstrate performance for two critical prototype infections, namely bloodstream infections (BSI) and periprosthetic joint infections (PJI).
This diagnostic test will be easy to implement and may also function as an early detection system to prevent cross-border spread of pathogens.
To guide the implementation of the tools developed through DRAIGON, an extensive health technology assessment (HTA) will be performed.
This assessment will consider:
-
Health-economic implications
-
Patient outcomes
-
Social issues


Research Team

Lim Lin Xenia
Camtech

Cornelis Boersma
HEC

Yehudit Bergman
JHU

Sujeesh Sebastian
OSS

Sylvia Debast
Isala

Maria João Cardoso
UMCG

Bhanu Sinha
UMCG

Meng Han Kuok
Camtech

Priscilla Anyimiah
HEC

Trish Simner
JHU

Jochen Hofstaetter
OSS

Tim Severs
Isala

Anurag Bari
UMCG

John Rossen
UMCG

Daniel Kirilly
Camtech

Simon van der Pol
HEC

Karina Hackl
OSS

Susana Hartmann
OSS

John Rossen
Isala

Roland Martzy
UMCG

Maarten Postma
HEC

Silva Tafaj
UHSN

Sofia Berdalli
OSS

Hendrik Gremmels
Isala

Janine de Zeeuw
UMCG

Basil Britto Xavier
UMCG
Check the latest news:
Connect on LinkedIn: Join our professional network to connect with like-minded individuals, participate in discussions, and stay abreast of industry trends.
Follow us on X: Connect with us on X for regular updates, insightful articles, and opportunities to engage with our community.